Structural and functional diversity of blood group antigens

Transfusion Clinique et Biologique

Volumn 8, Issue 3, 2001, Pages 163-199

  Cartron, J P ^a   Colin, Y ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Blood group antigen; Functional diversity; Structural diversity; Structure function relationship

Indexed keywords

BLOOD GROUP ANTIGEN; CELL ADHESION MOLECULE; CELL ENZYME; GLYCOLIPID; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; RECEPTOR PROTEIN; STRUCTURAL PROTEIN;

ANTIGEN DETECTION; ANTIGEN FUNCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL MEMBRANE; CHANNEL GATING; COMPLEX FORMATION; CONFERENCE PAPER; HUMAN; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN TRANSPORT; SEROLOGY; STRUCTURE ANALYSIS;

EID: 0034921897     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(01)00142-2     Document Type: Conference Paper

References (391)

1. ISBT working party on terminology for red cell antigens
2. Vers une approche moléculaire de la structure, du polymorphisme et de la fonction des antigènes de groupes sanguins
3. Human erythrocyte antigen expression: Its molecular basis
4. Molecular insights into blood groups and implication for blood transfusion
5. Application of molecular biology techniques to transfusion medicine
6. Towards an understanding of the red cell surface
7. Molecular basis of red cell protein antigen deficiencies
8. Insights into the structure and function of membrane polypeptides carrying blood group antigens
9. Erythrocyte blood group antigens: Not so simple after all
10. Functional aspects of red cell antigens
11. Blood group antigens on complement receptor/regulatory proteins
12. Functional roles of blood group antigens
13. Biological functions of blood group antigens
14. The structure and function of Band 3 (AE1): Recent developments
15. The spectrin-actin junction of erythrocyte membrane skeleton
16. Genetics of the red cell membrane skeleton
17. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum
18. Erythrocyte membrane alterations in Plasmodium falciparum malaria sequestration
19. Molecular basis of antigenic specificity in the ABO, H and Lewis blood group systems
20. The blood group-specific human glycosyltransferases
21. Molecular genetics of ABO
22. Molecular genetics of H
23. Advances in molecular genetics of ???- and ??3/4-fucosyltransferases
24. Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer
25. ABH and Lewis histo-blood group antigens in cancer
26. The role of blood group antigens in malignant progression, apoptotic resistance, and metastatic behavior
27. The human rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast
28. Erythrocyte membrane transport physiology
29. Transmembrane folding of the human erythrocyte anion exchanger (AE1, Band 3) determined by scanning and insertional N-glycosylation mutagenesis
30. Topology of the membrane doamin of the human erythrocyte anion exchange protein, AE1
31. Structural model for the organization of the transmembrane spans of the human red cell anion exchanger (Band 3; AE1)
32. Erythrocyte Band 3 antigens and the Diego blood group system
33. Red cell antigens on Band 3 and glycophorin A
34. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte Band 3: A site of interaction between Band 3 and glycophorin A under certain conditions
35. Glycophorin A facilitates the expression of human Band 3-mediated anion transport in Xenopus oocytes
36. Glycophorin A dimerization and Band 3 interaction during erythroid membrane biogenesis: In vivo studies in human glycophorin A transgenic mice
37. Functional cell surface expression of Band 3, the human red blood cell anion exchanger protein (AE1), in K562 erythroleukemia cells: Band 3 enhances the cell surface reactivity of Rh antigens
38. Coexpression of Band 3 mutant and Rh polypeptides: Differential effects of Band 3 on the expression of the Rh complex containg D polypeptide and the Rh complex containing the mLEe polypeptide
39. Human erythrocyte aging: Cellular and molecular biology
40. Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro
41. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum
42. Cellular and molecular mechanisms of senesecent erythrocyte phagocytosis by macrophages
43. Oxidation and erythrocyte senescence
44. Evaluation of biochemical changes during the in vivo erythrocyte senescence in the dog
45. Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-Band 3 and anti-spectrin antibodies
46. Sequestration in Plasmodium falciparum malaria: Sticky cells and sticky problems
47. Erythrocyte membrane alterations in Plasmodium falciparum malaria sequestration
48. Cerebral malaria
49. Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology
50. Molecular basis of sickle cell-endothelial cell interactions
51. Pathogenesis and treatment of sickle cell disease
52. Adhesive interactions of sickle erythrocytes with endothelium
53. Erythroid Band 3 variants and disease
54. Disorders of the red cell membrane
55. Hereditary spherocytosis: A review of the clinical and molecular aspects of the disease
56. bicêtre: R490C) associated with dominant hereditary spherocytosis causes defective membrane targeting of the molecule and a dominant negative effect
57. Trafficking and folding defects in hereditary spherocytosis mutants of the human red cell anion exchanger
58. Selective depression of blood group antigens associated with hereditary ovalocytosis among Melanesians
59. Invasion of hereditary ovalocytes by Plasmodium falciparum in vitro and its relationship to intracellular ATP concentration
60. Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis Band 3
61. Familial renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3: AE1) gene
62. Novel AE1 mutations in recessive distal renal tubular acidosis
63. Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: Loss of up to 95% Band 3 transport in red cells
64. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis
65. Alpha-mannosidase II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis
66. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia, type II (HEMPAS)
67. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genome-wide search
68. Cloning of the zebra fish retsina gene: Band 3 mutations result in dyserythropoiesis and apoptosis
69. Targeted disruption of the murine erythroid Band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton
70. Anion exchanger 1 (Band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton
71. Targeted inactivation of murine Band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo
72. Erythroid phosphatidylserine exposure is not predictive of thrombotic risk in mice with hemolytic anemia
73. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell Band 3 in cattle due to a nonsense mutation
74. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of Band 3
75. Pathophysiology of the aquaporin water channels
76. Cellular and molecular biology of the aquaporin water channels
77. Structure and function of aquaporin water channels
78. Three-dimensional structure of aquaporin-1
79. Structural determinants of water permeation through aquaporin-1
80. Pathogenetic significance of 'pure' monosomy 7 in myeloproliferative disorders, analysis of 14 cases
81. A novel form of congenital dyserythropoietic anemia associated with deficiency if erythroid CD44, and a unique blood group phenotype (In[a-b-], Co[a-b-])
82. Human red cell aquaporin CHIP-II expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia
83. Functional analysis of aquaporin-1 deficient red cells. The Colton-null phentotype
84. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels
85. A single mutation inside the NPA motif of aquaporin-1 found in a Colton-null phenotype
86. Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels
87. Reduced water permeability and altered ultrastructure in thin descending limb of Henle in aquaporin-1 null mice
88. Physiological importance of aquaporins: Lessons from knockout mice
89. Urinary concentrating defect in aquaporin-1 null patients
90. Evidence for the presence of aquaporin-3 in human red blood cells
91. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels
92. Jk(a-b-) red blood cells resist urea lysis
93. Urea transport deficiency in Jk(a-b-) erythrocytes
94. Cloning and functional expression of a urea transporter from human bone marrow cells
95. At physiological expression levels the Kidd blood group/urea transporter protein is not a water channel
96. Urea transporters in kidney and erythrocytes
97. Tandem sequence repeats in urea transporters: Identification of an urea transporter signature sequence
98. Kidd blood group and urea transport function of human erythrocytes are carried by the same protein
99. null individuals
100. Molecular characterization of a new urea transporter in the human kidney
101. Dominant optic atrophy: Exclusion and fine genetic mapping of the candidate gene, HRY
102. Association between Kidd blood group and congenital malformations
103. The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility
104. Cloning and characterization of the urea transporter UT3. Localization in rat kidney and testis
105. Endothelial cells of the kidney vasa recta express the urea transporter HUT1
106. Structure, regulation and physiological roles of urea transporters
107. An economy of water in renal function referable to urea
108. Urine concentration and dilution
109. Urea transport in the kidney
110. Osmotic stability of red cells in renal circulation requires rapid urea transport
111. The Kidd blood group and urea transport
112. Molecular heterogeneity of the Jk-null phenotype: Expression analysis of the JkS291P) mutation found in Finns
113. Genomic characterization of the Kidd blood group gene: Different molecular basis of the Jk(a-b-) phenotypes in Polynesians and Finns
114. A novel molecular basis of the Jk(a-b-) phenotype in a Swiss family
115. Partial deletion in the JK locus causing a Jk-null phenotype
116. Distribution of mRNA for the facilitated urea transporter UT3 in the rat nervous system
117. RACH2, a novel human gene that complements a fission yeast cell cycle checkpoint mutation
118. Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone
119. Molecular biology of Rh antigens
120. Rh blood group antigens: Protein and gene structure
121. Biochemical aspects of the blood group Rh (rhesus) antigens
122. Defining the Rh blood group antigens. Biochemistry and molecular genetics
123. Topology and organization of human Rh (rhesus) blood group-related polypeptides
124. Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region
125. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis
126. Gene organization and rearrangements at the human rhesus blood group locus revealed by fiber-FISH analysis
127. RHD gene deletion occured in the rhesus box
128. Organisation of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family
129. null disease
130. Molecular insights into the Rh protein family and associated antigens
131. Molecular characterization of qualitative Rh variants
132. The rhesus blood group system: Insights from recent advances in molecular biology
133. The Rh blood group system: A review
134. Molecular biology and genetics of the Rh blood group system
135. The Rh polypeptide is a major fatty acid acylated erythrocyte membrane protein
136. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex
137. K562 cells expressing RhD polypeptide with a Cys285 to Ala mutation have a normal D antigen
138. Weak D alleles express distinct phenotypes
139. Immunochemical analysis of the human erythrocyte Rh polypeptides
140. Association of Rh(D) polypeptides with the membrane skeleton in Rh(D) positive cells
141. The rhesus (D) polypeptide is linked to the human erythrocyte cytoskeleton
142. o (D) antigen
143. Flow cytometric analysis of the association between blood group related proteins and the detergent-insoluble material of K562 cells and erythroid progenitors
144. Direct evidence for in situ interaction between Rh complex and membrane skeleton in intact red cells
145. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation
146. The expression of human blood group antigens during erythropôiesis in a cell culture system
147. Surface expression of Rh-associated glycoprotein (RhAG) in non erythroid COS-1 cells
148. Post-transcriptional regulation of recombinant RhD membrane expression by the RhAG glycoprotein in K562 cells
149. Expression of RHD and RHCE gene products using retroviral transduction establishes the molecular basis of Rh blood group antigens
150. Expression of C antigen in transduced K562 cells
151. Site-directed mutagenesis of the human D antigen: Definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells
152. Molecular configuration of RhD epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemic cells
153. RH blood group system and molecular basis of Rh-deficiency
154. Normal red cell membrane expression of Rh and RhAG polypeptides in CD47-deficient mice
155. Effect of Rh-null asociated missense mutations on the RHAG gene on the cell surface expression of recombinant RhAG and RhD proteins in K562 cells
156. Role of CD47 as a marker of self on red blood cells
157. Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency
158. Isolation of cDNA clones for a 50 kDa glycoprotein of the erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression
159. Sequences and evolution of mammalian RH gene transcripts and proteins
160. The members of the RH gene family (RH50 and RH30) followed different evolutionary pathways
161. Conserved evolution of the RH50 gene compared to its homologuous Rh blood group gene
162. Structural analysis of the RH-like blood group genes products in nonhuman primates
163. Evolution of the human RH (rhesus) blood group genes: A 50 year old prediction (partially) fulfilled
164. The rhesus system
165. Sequence, organization, and evolution of Rh50 glycoprotein genes in nonhuman primates
166. Evolutionary history of the Rh blood group-related genes in vertebrates
167. + transporters
168. The MEP2 ammonium permease regulates pseudohyphal differentiation in Saccharomyces cerevisiae
169. Characterization of human RhCG and mouse RhCG as novel nonerythroid Rh glycoprotein homologues predominantly expressed in kidney and testis
170. Rh type B glycoprotein is a new member of the Rh superfamily and a putative ammonia transporter in mammals
171. New insights into the Rh superfamily of genes and proteins in erythroid and non erythroid tissues
172. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry
173. null erythrocytes
174. Phosphatidylserine exposure and aminophospholipid translocase activity in Rh-deficient erythrocytes
175. A subfamily of P-type ATPases with aminophospholipid transporting activity
176. Cloning, expression, and chromosomal mapping of a human ATPase II gene, member of the third subfamily of P-type ATPases and orthologous to the presumed bovine and murine aminophospholipid translocase
177. A family of ammonium transporters in Saccharomyces cerevisiae
178. Ammonia and glutamine metabolism during liver insufficiency: The role of kidney and brain in interorgan nitrogen exchange
179. + transport in the kidney
180. Ammonium transport by the tick ascending limb of Henle's loop
181. Ammonium carriers in medullary thick ascending limb
182. Rhesus factors and ammonium: A function in efflux
183. Ammonium in nervous tissue: Transport across cell membranes, fluxes from neurons to glial cells and role in signalling
184. Localization of the Rh50-like protein to the contractile vacuole in Dictyostelium
185. Erythrocyte signal transduction pathways and their possible functions
186. Blood groupantigens as tumor markers, parasitic/bacterial/vireal receptors, and their association with immunologically important proteins
187. Blood group antigens as receptors for pathogens
188. Blood group associations with parasites, bacteria, and viruses
189. Animal glycosphingolipids as membrane attachment sites for bacteria
190. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
191. Human parvorirus B19 infection
192. Recombinant human parvovirus B19 vectors: Erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells
193. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigen
194. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging
195. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin
196. Molecular mimicry between Helicobacter pylori and the host
197. Vanderbroucke-Grauls CMJE Why Helicobacter pylori has Lewis antigens
198. Helicobacter pylori, an adherent pain in the stomach
199. k). Strain differences indicate receptor heterogeneity and two pathways for invasion
200. Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum
201. EBA-175: An erythrocyte-binding ligand of Plasmodium falciparum
202. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes
203. Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175
204. The invasion of erythrocytes by malarial merozoites
205. Molecular aspects of severe malaria
206. Adhesive repetors on malaria-parasited red cells
207. Central nervous system in cerebral malaria: "Innocent bystander" or active participant in the induction of immunopathology
208. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1
209. The Duffy-binding like domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding
210. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1
211. The Duffy blood group antigen: An update
212. From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen
213. The Duffy protein: A malarial and chemokine receptor
214. Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor
215. Identification of the erythrocyte binding domains of P. vivax and P. knowlesi proteins involved in invasion
216. The large diversity gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes
217. Chemokine receptors and HIV-1: An attractive pair?
218. Récepteurs de chimiokines et entrée du VIH
219. Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines
220. The neutral glycosphingolopid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope protein
221. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficieny virus type 1 (HIV-1) entry: Evidence for CD44-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids. (Gb3 and GM3)
222. Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells
223. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
224. Emergence of a FY*Anull in a Plasmodium vivax-endemic region of Papua New Guinea
225. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood stage infection
226. Evidence for a new mechanism abolishing expression of the FY/DARC locus
227. Expression and binding properties of a soluble chimeric protein containg the N-terminal domain of the Duffy antigen
228. Characterization of the Fya and Fyb epitopes recognized by monoclonal antibodies on the Duffy antigen receptor for chemokines
229. The promiscuous chemokine binding profile of the Duffy Antigen/Receptor for Chemokines is primarily localized to sequences in the amino-terminal domain
230. Partial site-directed mutagenesis analysis of the Duffy antigen/receptor for chemokines
231. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes
232. Close association of the first and fourth extracellular domains of the Duffy Antigen/Receptor for Chemokines by a disulfide bond is required for ligand binding
233. Red blood cells are a sink for interleukine 8, a leukocyte chemotaxin
234. Deletion of the murine Duffy gene (Fy) reveals that the Duffy recptor is functionally redundant
235. Exaggerated response to endoxin in mice lacking the Duffy antigen/Receptor for chemokines (DARC)
236. Transcytosis and surface presentation of IL8 by venular endothelial cells
237. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggest a role in leukocyte activation, chemotaxis, and angiogenesis
238. Up-regulation of Duffy antigen receptor expression in children with renal disease
239. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis
240. Alpers CE. Expression of chemokines and chemokine receptors during human renal transplant rejection
241. Signaling at zero G: G-protein-independent functions of 7-TM receptors
242. Adhesion receptors of the immune system
243. Cell adhesion molecules
244. The molecular structure of cell adhesion molecules
245. Sticking together and sorting things out: Adhesion as a force in development
246. Red blood cell surface adhesion molecules: Their possible roles in normal human physiology and disease
247. Erythroid cell adhesion molecules
248. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
249. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter
250. Reccurent severe infections caused by a novel leukocyte adhesion deficiency
251. Leukocyte adhesion deficiency type II
252. Type C-lectins and sialyl Lewis X oligosaccharides: Versatile roles in cell-cell interaction
253. Adhesion receptors on haematopoietic progenitor cells
254. Importance of cell-cell interactions in regulation of erythropoiesis
255. Role of bone marrow matrix in normal and abnormal hematopoiesis
256. Erythroid cell adhesion molecules Lutheran and LW in health and disease
257. Endothelial cells in physiology and in the pathophysiology of vascular disorders
258. Role of red blood cells in thrombosis
259. Sickle cell disease
260. Pathogenesis and treatment of sickle cell disease
261. New concepts in assessing sickle cell disease severity
262. The non-expression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia
263. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea
264. Fetal hemoglobin in sickle celf anemia: Relationship to erythrocyte adhesion markers and adhesion
265. Advanced glycation end-products: A review
266. RAGE: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation
267. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms
268. Forms and functions of CD44
269. CD44 isoforms and leukemic hematopoiesis
270. CD44 cell adhesion molecules
271. b blood group antigens are located on a glycoprotein of 80.000 MW (the CDw44 glycoprotein) whose expression is inflenced by the In(Lu) gene
272. CD44 is the principal cell surface receptor for hyaluronate
273. A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding
274. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44, and a unique blood group phenotype [In(a-b-), Co(a-b-)]
275. Human red cell aquaporin CHIP-II-Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia
276. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia
277. CD44 regulates hematopietic tissue distribution, granuloma formation and tumorigenicity
278. The lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver
279. A unique gene encodes spliceoforms of the B-CAM cell surface glycoprotein of epithelial cancer and the Lutheran blood group glycoprotein
280. Non polarized expression of basal cell adhesion molecule B-CAM in epithelial ovarian cancers
281. Basal cell adhesion molecule/lutheran protein: The receptor critical for sickle cell adhesion to laminin
282. The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules
283. Use of domain-deletion mutants to locate Lutheran blood group antigens to each of the five immunoglobulin superfamily domains of the Lutheran glycoprotein: Elucidation of molecular basis of the Lu(a)/Lu(b) and the Au(a)/Au(b) polymorphisms
284. Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity
285. Characterization of the laminin binding domains of the Lutheran blood group glycoprotein
286. The molecular background of recessive Lu(a-b-) phenotype in a japanese family
287. Interactions of Lutheran/B-CAM proteins with laminin and erythroid cytoskeleton: Characterization of the interacticn sites
288. Isoforms of the Lutheran/basal cell adhesion molecule glycoprotein are differentially delivered in polarized epithelial cells. Mapping of the basolateral signal to a cytoplasmic di-leucine motif
289. Basal-Cell Adhesion Molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites
290. Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses
291. The LW blood group glycoprotein is homologous to intercellular adhesion molecules
292. The red cell LW blood group protein is an intercellular adhesion molecule (ICAM-4) which binds to CD11/CD18 leukocyte integrins
293. A novel leukointegrin, alpha d beta2, binds preferentially to ICAM-3
294. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus
295. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
296. Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface
297. Analysis of the binding site on intercellular adhesion molecule 3 for the leukocyte integrin lymphocyte function-associated antigen 1
298. Localization of the binding site on intercellular adhesion molecule-3 (ICAM-3) for lymphocyte function-associated antigen 1 (LFA-1)
299. Binding sites of leukocyte beta2 integrins (LFA-1, Mac-1) on the human ICAM-4/LW blood group protein
300. Adhesive recognition sequences
301. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine
302. Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin
303. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin
304. An ovarian tumor marker with homology to vaccinia virus containing an IgV-like region and multiple transmembrane domains
305. null human erythrocytes
306. Integrin-associated protein (CD47) and its ligands
307. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric G proteins
308. CD47 and death signaling in the immune system
309. Signal regulation by family conspiracy
310. CD47-signal regulatory protein alpha (SIRP alpha) regulates Fcgamma and complement receptor-mediated phagocytosis
311. Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin
312. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice
313. a blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues
314. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule
315. HT7, neurothelin, basigin, gp42 and OX-47 - Many names for one developmentally regulated immunoglobulin-like surface glycoprotein on blood-brain barrier endothelium, epithelial tissue barriers and neurons
316. Tumor cell-derived stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase
317. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily
318. CD 147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway
319. Regulation of mmP-1 and mmP-2 production through CD147/extracellular matrix metalloproteinase inducer interaction
320. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression
321. Unavailability of CD 147 leads to selective erythrocyte trapping in the spleen
322. Roles of basigin, a member of the immunoglobulin superfamily, in behavior as to an irritating odor, lymphocyte response, and blood-brain barrier
323. Retinal dysfunction in basigin deficiency
324. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important role in peri-implantation development and spermatogenesis
325. Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily
326. The Xg blood group system: A review
327. The MIC2 gene product: Epitope mapping and structural, prediction analysis define an integral membrane protein
328. A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes
329. + thymocytes
330. CD99 (MIV2) regulates the LFA- 1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cell adhesion
331. Cloning of PBDX, an MIC2-related gene that spans the pseudoautosomal boundary on chromosome Xp
332. PBDX is the XG blood group gene
333. Evidence that CDw108 membrane protein bears the JMH blood group antigen
334. Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108
335. Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins
336. New eukaryotic semaphorins with close homology to semaphorins of DNA viruses
337. Semaphorins and their receptors in vertebrate and invertebrates
338. Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules
339. Molecular cloning, expression and uses of mammalian glycosyltransferases
340. Molecular genetics of the ABO histo-blood group system
341. Molecular genetics of α-L-fucosyltransferase genes (H, Se, Le, FUT4, FUT5 and FUT6)
342. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globoseries glycosphingolipids
343. Cloning and expression of the histo-blood group Pk UDP-galactose: Ga1β1-4G1cβ-cerα1, 4-galactosyltransferase. Molecular genetic basis of the p phenotype
344. Molecular basis for the p phenotype. Identification of distinct and multiple mutations in the α1-4galatactosyl transferase gene in swedish and japanese individuals
345. The P blood group system: Biochemical, serological and clinical aspects
346. The P blood group system: Recent progress in immunochemistry and genetics
347. x related structures as adhesion molecules
348. Ley/H: An endothelial-selective, cytokine-inductible, angiogenic mediator
349. Kell, Kx and the McLeod syndrome
350. The Kell blood group system: Kell and XK membrane proteins
351. Functional and structural aspects of the Kell blood group system
352. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein
353. Expression of Kell blood group protein in non erythroid tissues
354. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells
355. Kell and Kx, two disulfide-linked proteins of the human erythrocyte membrane are phosphorylated in vivo
356. Mammalian membrane metallopeptidases: NEP, ECE, Kell, and PEX
357. Proteolytic processing of big endothelin-3 by the Kell blood group protein
358. Molecular basis of Kell blood group phenotypes
359. The Kell blood group system and the McLeod phenotype
360. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides
361. Molecular basis of the Kell-null phenotype
362. Molecular defects underlying the Kell null phenotype
363. Neuroacanthocytosis a clinical, haematological and pathological study of 19 cases
364. McLeod syndrome: A distinct form a neuroacanthocytosis
365. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia
366. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia
367. Erythropoietic suppression in fetal anemia be cause of Kell alloimmunization
368. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins
369. Evidence that the human blood group antigens Gya and Hy are carried on a novel glycosylphosphatidylinositol-linked erythrocyte membrane protein
370. Dombrock blood group (DO) assignment to chromosome 12p
371. Gene expression in proliferating human erythroid cells
372. Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyl transferase gene family
373. Mono(ADP-ribosyl) transferases and related enzymes in animal tissues
374. Diphteria toxin/dependent adenosine diphosphate ribosylation of amino acyl transferase II and inhibition of protein synthesis
375. Molecular basis associated with the Dombrock null phenotype
376. null phenotype
377. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism
378. Defective glycosylphosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria
379. The molecular basis of paroxysmal nocturnal hemoglobinuria
380. Human erythrocyte glycophorins: Protein and gene structure analysis
381. Molecular genetics of the glycophorin A gene cluster
382. MNSs blood group and major glycophorins. "Molecular basis of major human blood groups antigens"
383. The role of red cell glycophorins in regulating membrane function. "Protein blood group antigens of the human red cell"
384. Glycophorin C and related glycoproteins: Structure, function and regulation
385. Glycophorins C and D are generated by the use of alternative translation initiation sites
386. Evidence that the red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C
387. Regulation of red cell membrane protein interactions: Implication for red cell function
388. Regulation of the glycophorin C-protein 4.1 membrane-to-skeleton bridge and evaluation of its contribution to erythrocyte membrane stability
389. Modulation of Band 3-ankyrine interaction by protein 4.1
390. 2+ and calmodulin, implications for modulation of CD44-ankyrin interaction
391. Universal RBCs